Table 4.
Plasma fatty acid composition and product to substrate ratios in the third trimester by maternal alcohol and smoking status1
| Control | AE-only | AE+Smoker | Sig | Control | AE-only | AE+Smoker | Sig | ||
|---|---|---|---|---|---|---|---|---|---|
| N=44 | N=44 | N=17 | N=44 | N=44 | N=17 | ||||
| Saturated | Desaturation | ||||||||
| C14:0 | 1.11±0.08 | 0.99±0.08 | 1.05±0.12 | 0.554 | 16:1n7/16:0 | 0.05±0.00a,b | 0.04±0.00a | 0.07±0.00b | <0.001 |
| C16:0 | 26.04±0.38a,b | 25.13±0.38a | 27.05±0.59b | 0.023 | 18:1n9/18:0 | 3.00±0.08 | 3.00±0.08 | 3.19±0.12 | 0.380 |
| C18:0 | 6.23±0.12 | 6.53±0.12 | 6.47±0.19 | 0.244 | 18:3n6/18:2n6 | 0.005±0.00a,b | 0.004±0.00a | 0.006±0.00b | 0.006 |
| C20:0 | 0.13±0.01 | 0.12±0.01 | 0.12±0.01 | 0.779 | 20:4n6/20:3n6 | 2.98±0.18a | 3.94±0.18b | 3.69±0.28a,b | 0.002 |
| C22:0 | 0.19±0.01 | 0.21±0.01 | 0.19±0.02 | 0.589 | Elongation | ||||
| C24:0 | 0.16±0.01 | 0.15±0.01 | 0.15±0.01 | 0.787 | 18:0/16:0 | 0.24±0.01 | 0.26±0.01 | 0.24±0.01 | 0.092 |
| Monounsaturated | 22:4n6/20:4n6 | 0.05±0.00a | 0.04±0.00b | 0.05±0.00a,b | 0.005 | ||||
| C16:1n7 | 1.30±0.09b | 1.11±0.09b | 1.92±0.14a | <0.001 | 22:5n3/20:5n3 | 1.49±0.11a,b | 1.20±0.11a | 1.70±0.17b | 0.029 |
| C18:1n9 | 18.53±0.37a | 19.21±0.37a,b | 20.32±0.58b | 0.040 | Fatty Acid Ratios | ||||
| C20:1n9 | 0.21±0.01 | 0.23±0.01 | 0.23±0.02 | 0.309 | 16:0/18:2n6 | 0.78±0.03a,b | 0.74±0.03a | 0.89±0.04b | 0.008 |
| C24:1n9 | 0.26±0.02 | 0.21±0.02 | 0.25±0.04 | 0.415 | 18:2n6/18:3n3 | 193.46±11.71 | 191.41±11.60 | 169.28±18.20 | 0.511 |
| Omega-6 | 20:4n6/20:5n3 | 32.20±3.37a,b | 27.91±3.34a | 46.97±5.24b | 0.011 | ||||
| C18:2n6 | 34.39±0.70a,b | 34.75±0.69a | 31.46±1.09b | 0.035 | 22:5n6/22:6n3 | 0.11±0.01a | 0.11±0.01a | 0.19±0.02b | <0.001 |
| C18:3n6 | 0.16±0.01a,b | 0.13±0.01a | 0.17±0.01b | 0.014 | 22:5n6/22:4n6 | 0.82±0.05a | 0.93±0.04a,b | 1.01±0.07b | 0.006 |
| C20:2n6 | 0.44±0.03 | 0.35±0.03 | 0.41±0.04 | 0.084 | 22:6n3/22:5n3 | 8.42±0.31 | 8.14±0.31 | 8.38±0.48 | 0.810 |
| C20:3n6 | 1.64±0.07a | 1.29±0.07b | 1.55±0.11a,b | 0.006 | Omega 6:Omega 3 | 17.13±0.89 | 16.63±0.88 | 19.92±1.39 | 0.130 |
| C20:4n6 | 4.60±0.17 | 4.87±0.17 | 4.93±0.27 | 0.461 | |||||
| C22:4n6 | 0.24±0.01a | 0.20±0.01b | 0.24±0.02a,b | 0.023 | |||||
| C22:5n6 | 0.19±0.02a | 0.19±0.02a | 0.27±0.02b | 0.013 | |||||
| Omega-3 | |||||||||
| C18:3n3 | 0.20±0.01 | 0.20±0.01 | 0.21±0.02 | 0.993 | |||||
| C20:5n3 | 0.22±0.04a,b | 0.35±0.04a | 0.14±0.06b | 0.010 | |||||
| C22:5n3 | 0.24±0.01a,b | 0.26±0.01a | 0.19±0.02b | 0.029 | |||||
| C22:6n3 | 1.95±0.09a | 2.06±0.09a | 1.51±0.14b | 0.005 | |||||
| Total Fatty Acids (μg/ml) | 4670.39±144.92 | 4599.47±146.61 | 4505.06±255.17 | 0.828 |
Estimated marginal means ± standard error of mean (SEM) by general linear model. Individual plasma fatty acids are presented as a percent of total fatty acids. Means in a row with different superscript letters differ with a p value < 0.05. Models were adjusted for SES, site, pre-pregnancy BMI, and gestational age at blood draw. Two subjects in the AE+Smoker group had a missing variable for pre-pregnancy BMI thus were not included in this analysis.